Watch Conspiracy Theory w/ Jesse Ventura - Bilderberg

Conspiracy Theory w/ Jesse Ventura - Bilderberg

They're thought to be a group of the world's elite who meet once a year at a luxury hotel and decide how they will run the world. It's believed they plan to thin out the population through disease-and vaccines. Jesse Ventura infiltrates the Bilderberg Group


Watch Conspiracy theory, Jesse Ventura, Bilderberg episode online free:
download conspiracy.theory.with.jesse.venturas.01e05.pdtv.xvid.avi rapid mega video torrent zip

http://www.megavideo.com/?v=1EXTJG2V

http://www.mrbrownee70.com/?id=49Z6L648T - high def



excellent episode on the bilderberg group. Jesse ventura did a great job! -st0ckman



If you found this article interesting please subscribe for updates with any reader or your email. Also be sure to check out my soon to launch membership website TheStockman.ORG,

Bookmark & Share on ANY social site:

XXDR TB: Highly Infectious and Highly Resistant to Antibiotics

Frequency Foundation has reported on this previously and developed frequencies for XXDR TB. These were distributed to Frequency Foundation subscribers some months ago.

From a frequency point of view this is just another bacteria associated with a set of parasites and viruses that enable it to flourish. However, from a public health point of view it can be a disaster as conventional medicine has no good solution.

First Case of Highly Drug-Resistant TB Found in US

It started with a cough, an autumn hack that refused to go away.  Then came the fevers. They bathed and chilled the skinny frame of Oswaldo Juarez, a 19-year-old Peruvian visiting to study English. His lungs clattered, his chest tightened and he ached with every gasp. During a wheezing fit at 4 a.m., Juarez felt a warm knot rise from his throat. He ran to the bathroom sink and spewed a mouthful of blood.

I’m dying, he told himself, “because when you cough blood, it’s something really bad.”
It was really bad, and not just for him.

Doctors say Juarez’s incessant hack was a sign of what they have both dreaded and expected for years â€" this country’s first case of a contagious, aggressive, especially drug-resistant form of tuberculosis. The Associated Press learned of his case, which until now has not been made public, as part of a six-month look at the soaring global challenge of drug resistance.

Juarez’s strain â€" so-called extremely drug-resistant (XXDR) TB â€" has never before been seen in the U.S., according to Dr. David Ashkin, one of the nation’s leading experts on tuberculosis. XXDR tuberculosis is so rare that only a handful of other people in the world are thought to have had it.

“He is really the future,” Ashkin said. “This is the new class that people are not really talking too much about. These are the ones we really fear because I’m not sure how we treat them.”

Forty years ago, the world thought it had conquered TB and any number of other diseases through the new wonder drugs: Antibiotics. U.S. Surgeon General William H. Stewart announced it was “time to close the book on infectious diseases and declare the war against pestilence won.”

Today, all the leading killer infectious diseases on the planet â€" TB, malaria and HIV among them â€" are mutating at an alarming rate, hitchhiking their way in and out of countries. The reason: Overuse and misuse of the very drugs that wer e supposed to save us.

NYSE Arca Morning Update - 08:30:00 ET

NYSE Arca Morning Update for Thursday, Dec 31, 2009 :

STOCKS TRADING ON NYSE Arca AT A PRICE 15% OR MORE AWAY FROM
THE PREVIOUS TRADE DAY'S CONSOLIDATED CLOSE PRICE (AS OF 08:30:00 ET)

Stock Wednesday's Close Current Price Pct Change Current NYSE ARCA Vol
QUIX $2.94 $6.30 114% 21,296
IDN $2.39 $3.21 34.1% 18,762
BIOD $4.10 $4.85 18.3% 27,690

10 MOST ACTIVE STOCKS ON NYSE ARCA AS OF 08:30:00 ET

BASED ON DOLLARS TRADED: | BASED ON SHARES TRADED:
Stock $ Volume Price PctChg | Stock Share Vol Price PctChg
SPY $20,297,403 $112.77 0.2% | C 730,591 $3.34 0.9%
GLD $12,648,395 $108.24 1.2% | SPY 179,951 $112.77 0.2%
AAPL $6,914,416 $212.71 0.6% | GLD 116,907 $108.24 1.2%
EEM $2,647,749 $41.57 0.6% | SEED 102,352 $12.66 ( 0.8%)
C $2,432,211 $3.34 0.9% | ICXT 97,623 $9.60 13.0%
MT $2,096,996 $46.60 0.8% | EEM 63,635 $41.57 0.6%
SDS $1,698,716 $34.26 ( 0.4%) | SDS 49,600 $34.26 ( 0.4%)
QQQQ $1,431,242 $46.22 0.1% | BAC 49,403 $15.11 0.3%
SEED $1,297,481 $12.66 ( 0.8%) | MT 45,000 $46.60 0.8%
FXI $1,259,264 $42.53 1.2% | FNM 40,720 $1.17 0.9%

Price changes may be affected by symbol splits and dividends.

Consolidated close price is the last print (excluding prints with trade
conditions) prior to 4PM ET.

This information is also updated on our web page every morning at 8:35ET:
http://www.tradearca.com/data/volume/daily_update.asp

This material is for informational purposes only.
NYSE Euronext and its affiliates ("NYSE Arca") are not soliciting any action based upon it.
This material is not to be construed as an offer to buy or sell any security in any jurisdiction where such an offer or solicitation would be illegal.
Any opinions expressed in this material are NYSE Arca opinions only.
NYSE Arca undertakes no obligation to update any of the information contained in this material in light of new information or future events.
THIS MATERIAL IS PROVIDED BY NYSE ARCA "AS IS" AND WITHOUT WARRANTIES EXPRESS OR IMPLIED.
NYSE ARCA DISCLAIMS ALL WARRANTIES INCLUDING THE IMPLIED WARRANTIES OF MERCHANTIBILITY, TITLE, AND FITNESS FOR A PARTICULAR PURPOSE AS TO THIS MATERIAL.
IN NO EVENT SHALL NYSE ARCA BE LIABLE FOR DIRECT, INDIRECT, INCIDENTAL, PUNITIVE, OR CONSEQUENTIAL DAMAGES OF ANY KIND WHATSOEVER (INCLUDING BUT NOT LIMITED TO, LOST PROFITS, TRADING LOSSES AND DAMAGES THAT MAY RESULT FROM THE USE
OF THIS MATERIAL, ANY DELAY OR INTERRUPTION OF SERVICE OR OMISSIONS OR INACCURACIES IN THE MATERIAL) WITH RESPECT TO THIS MATERIAL.

Copyright [2009] by NYSE Euronext. All rights reserved. Reproduction and redistribution prohibited without prior express consent.

Taxes are still immoral and evil!

YouTube - Taxes are still immoral and evil!

If you found this article interesting please subscribe for updates with any reader or your email. Also be sure to check out my soon to launch membership website TheStockman.ORG,

Bookmark & Share on ANY social site: